---
title: "Ranibizumab - Diabetic Retinopathy"
sidebar: mydoc_sidebar
permalink: db01270-mesh-d003930-1.html
toc: false 
---


Path ID: `DB01270_MESH_D003930_1`
{% include image.html url="images/db01270-mesh-d003930-1.png" file="db01270-mesh-d003930-1.png" alt="db01270-mesh-d003930-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000069579">MESH:D000069579 </a> | Ranibizumab | Drug |
| <a href="https://identifiers.org/UniProt:P15692">UniProt:P15692 </a> | Vascular endothelial growth factor A | Protein |
| <a href="https://identifiers.org/GO:0001525">GO:0001525 </a> | Angiogenesis | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D003930">MESH:D003930 </a> | Diabetic retinopathy | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ranibizumab | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor A |
| Vascular Endothelial Growth Factor A | POSITIVELY REGULATES | Angiogenesis |
| Angiogenesis | POSITIVELY CORRELATED WITH | Diabetic Retinopathy |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01270](https://go.drugbank.com/drugs/DB01270)
  - [https://pubmed.ncbi.nlm.nih.gov/19199892/](https://pubmed.ncbi.nlm.nih.gov/19199892/)
